Add 'Can testosterone cause bulimia?'

16 hours ago · 30e1321114
1 changed files with 8 additions and 0 deletions
--- a/Can-testosterone-cause-bulimia%3F.md
+++ b/Can-testosterone-cause-bulimia%3F.md
@ -0,0 +1,8 @@
 <br>
 <br>Of note, treatment responders had significantly higher baseline concentrations of [buy testosterone online](https://digitalafterlife.org/@lorenza2221687?page=about), and the reduction in bulimic behavior was related to a decline in [buy testosterone injections](https://movieru.jp/portfolio/@sherriperez453?page=about) concentrations. Examining the impact of the oral contraceptive Yasmin® (drospirenone 3 mg, estradiol 0.03 mg; Schering, AG, Bergkamen, Germany) on bulimic symptomatology after a 3-month treatment cycle showed a reduction in compensatory behaviors, meal-related hunger and gastric distention in women with BN . Thus, it appears that high-dose estradiol in concentrations that do not replicate normal pubertal physiology are not beneficial in improving bone mass density in girls with AN, but that treatment mimicking normal pubertal development could be a beneficial adjunct to psychological treatment for AN.
 Ovarian hormones are therefore another set of biological factors that likely contribute to a sex-differentiated trajectory of risk and prevalence of eating pathology. Given that genetic contributions to eating pathology in girls emerge during gonadarche (independent of BMI)18,26–30 and the fact that steroid hormones can regulate gene transcription, recent research has explored whether pubertal ovarian hormones moderate genetic effects on eating pathology. These within-sex ovarian hormone effects could further inform understanding of sex-based differences in the biological basis of eating pathology. In the following sections, we review evidence of organizational and activational influences of sex steroid hormones on variability in risk for eating pathology across different life stages. In the subsequent sections, we review some of the specific biological factors, including sex-specific processes, that may contribute to sex differences in the etiology of eating pathology and may explain some of the sex-differentiated etiologic effects observed in twin research.
 Thus, future research should include attention to potential differences in risk and ED presentation in males, intersected with cultural and ethnic identification. For instance, males may be motivated to pursue rigid eating or exercise routines, as well as the use of appearance-enhancing or performance-enhancing drugs (eg, anabolic steroids) to achieve a muscular body idea. Bulimia nervosa is characterized by recurrent episodes of binge eating, the use of 1 or more compensatory strategies intended to offset the impact of binge episodes, and overvaluation of weight and shape.19 Lifetime prevalence estimates for BN among males range between 0.1% and 1.6%4,8,20,21 with males comprising approximately one-third of all BN cases in the general population.4,25 Compared with adult samples with BN, there is little empirical evidence of the adolescent experience of BN, and  [111.170.153.123](http://111.170.153.123:3000/jolene83661093) even less so among males. Along with the paucity of empirical research devoted solely to male populations, many full-scale clinical trials continue to exclude male patients on the premise of their assumed atypicality.14 Although many symptoms of ED among males may indeed be qualitatively different than for females, gold standard assessments for EDs demonstrate a lack of sensitivity in detecting and qualifying ED symptoms in males.15,16 Many EDs in males may be undetected, or at least indexed with symptoms that appear less in number or  [lasigal.com](https://lasigal.com/bebelou9409010) in severity. Currently, findings are most robust for the impact of estradiol on binge eating, indicating an ideal starting point from which to initiate this work. In line with this hypothesis, examining a continuous measure of disordered eating across the lifespan showed that eating disorder symptoms decrease after age 24 years. Consistent with what has been observed during puberty and pregnancy, the menopause transition may be an additional vulnerability period for eating disorder symptoms.
 During the menopause transition, estradiol and progesterone concentrations not only decrease substantially, but also fluctuate significantly on a day-to-day basis. Specifically, an initial case report suggests that estradiol facilitates the antidepressant effect of fluoxetine in menopausal women with major depression and is superior to antidepressant or estradiol treatment alone . However, it is currently unclear whether this is also true for eating disorder symptomatology, specifically binge eating. It appears that estradiol has a direct role in normal food intake while the role of progesterone is indirect. As discussed, bulimic symptomatology tends to increase when estradiol concentrations decrease and progesterone concentrations increase.
 Circulating estradiol concentrations are inversely related to binge eating in women with BN 32,33, suggesting that binge eating may increase in women with BN when estradiol concentrations decrease. Examining the association between estradiol and progesterone and eating disorder symptoms reveals an association with diminishing estradiol and increasing progesterone. Much of the research addressing the role of reproductive hormones in the development and maintenance of eating disorders has occurred within the past decade. Taken together, these facts have led many to postulate the role of reproductive hormones in eating disorders. The authors focus a majority of their discussion on women, as minimal research has addressed the association between reproductive hormones and eating disorders in men. Preliminary studies also suggest that hormone augmentation may be a beneficial adjunct to the standard treatment of choice for eating disorders. Thus, despite a growing literature, much more research is needed to further elucidate how biological mechanisms contribute to differential risk for eating pathology in males and females across the lifespan.
 In summary, clinical research examining the association between estradiol and progesterone concentrations and eating disorder symptoms and animal models of eating disorder symptoms, provide support for the role of these hormones in the activation of the abnormal eating behaviors that occur in eating disorders. Finally, animal studies provide additional evidence for the role of estradiol and progesterone in binge eating, and further implicate reproductive hormones in the etiology of eating disorders. In contrast to the prenatal/perinatal organization (e.g., masculinizing and defeminizing effects) from [buy testosterone pills](https://ahromov.pitbddma.org.ua/hormones-and-b-cell-development-in-health-and-autoimmunity/), ovarian hormones are not elevated in prenatal/perinatal development and do not play a major role at this stage of life.54 Thus, our review of ovarian hormones focuses on their organizational and activational actions on eating pathology during puberty, young adulthood, and midlife (perimenopause/menopause), and we only cover within-sex effects in females given a general absence of male data. The natural [buy testosterone online without prescription](https://tovegans.tube/@florhort16055?page=about) exposure during prenatal/perinatal development in males appears to impact sex differences in eating pathology by reducing risk in males relative to females; however, between-person variation in levels of circulating sex steroids, during and after puberty, could exert sex-specific effects that impact individual variation in risk among males and females and further contribute to sex-based differentiation in risk. Across studies, moderate male-female genetic correlations (rg ~.50–.70) have been found for eating pathology symptoms (e.g., weight/shape concerns, binge eating); thus, although some of the genetic factors that contribute to eating pathology are shared between the sexes, a proportion of genes are distinct.19–21 The presence of sex-specific genetic factors on eating pathology and related phenotypes (e.g., food intake, food preferences, weight maintenance functions) was also confirmed in a recent meta-analysis.32 This meta-analysis explored 50 phenotypic categories/clusters (comprised from 2,608 individual trait statistics) and found that only 25% of the tested phenotypes showed evidence for sex-specific genetic processes.32 Pathological eating is therefore among a relatively small proportion of conditions that have, to some extent, different genetic factors contributing to phenotypic expression in males versus females.
 <br>